Benign prostatic hyperplasia (BPH) affects millions of men, and many patients seek a minimally invasive alternative to major surgical treatment or to medications, which are discontinued by a third of BPH patients due to bothersome side effects and insufficient relief. Teleflex’s FDA-approved UroLift System for Prostatic Urethral Lift is that alternative: a minimally invasive approach to BPH, performed in outpatient or inpatient settings under general or local anesthesia. The UroLift System consists of the UroLift Delivery Device, inserted transurethrally, and the UroLift Implants, permanent implants deployed by the delivery device to hold obstructing prostatic lobes apart. Learn more about the UroLift System for BPH relief.
Your product information request has been received and we will forward information to the contact information you provided shortly.